Metronidazole ointment - SLA Pharma

Drug Profile

Metronidazole ointment - SLA Pharma

Alternative Names: Metronidazole 10% ointment - SLA Pharma AG; Topical metronidazole - SLA Pharma

Latest Information Update: 17 Sep 2015

Price : $50

At a glance

  • Originator SLA Pharma
  • Class Antibacterials; Antiprotozoals; Nitroimidazoles; Radiosensitisers; Small molecules
  • Mechanism of Action
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Crohn's disease
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Phase III Crohn's disease

Most Recent Events

  • 15 Mar 2016 Biomarkers information updated
  • 17 Sep 2015 Phase-III development is ongoing in USA and United Kingdom
  • 17 Sep 2015 Metronidazole ointment - SLA Pharma is available for licensing as of 17 Sep 2015. http://www.slapharma.com
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top